miRNA‐124 has been described as a tumor suppressor, preventing development of a malignant phenotype in the cancer cell by the downregulation of several pathways including STAT3 signaling in colorectal cancer or EZH2 in gastric and hepatocellular cancers 33, 34, 35. This evidence concerns the gene STAT3 and hepatocellular carcinoma.